Average Co-Inventor Count = 5.56
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. N30 Pharmaceuticals, Inc. (7 from 17 patents)
2. Crestone, Inc. (6 from 7 patents)
3. Nivalis Therapeutics, Inc. (5 from 19 patents)
4. 3m Innovative Properties Company (3 from 14,084 patents)
5. Coley Pharmaceutical Group, Inc. (2 from 41 patents)
6. Replidyne, Inc. (1 from 12 patents)
24 patents:
1. 9814700 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
2. 9498466 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
3. 9180119 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
4. 9145410 - Pyrazolopyridines and analogs thereof
5. 9138427 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
6. 9029402 - Pyrrole inhibitors of S-nitrosoglutathione reductase
7. 8957105 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
8. 8846736 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
9. 8716320 - Antibacteriall heterocyclic ureas
10. 8697720 - Substituted phenylether-thienopyridone compounds with antibacterial activity
11. 8691816 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
12. 8686015 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
13. 8673961 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
14. 8658670 - Methods and compounds for treatment of clostridium based infection
15. 8642628 - Pyrrole inhibitors of S-nitrosoglutathione reductase